课题基金 / 基金详情

Involvement of asparatic acid isomerization in the pathogenesis ofCOPD

Involvement of asparatic acid isomerization in the pathogenesis ofCOPD
天冬氨酸异构化参与COPD发病机制
批准号:
22590842
负责人:
YAMAUCHI Kohei
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

YAMAUCHI Kohei的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The pathogenesis of COPD involves posttranslational modification, including amino acid racemization and isomerization and damage in the protein induced by oxidative stress through mainly cigarette smoking. The modified and damaged proteins are susceptible to cell damage such as apoptosis or ER stress. Notably, asparatic acid and asparagine are more sensitive amino acids to oxidative stress. In the COPD cases, we investiga ted signs of oxidative stress from the point of asparatic acid isomerization in the proteins.Methods:Lung specimens surgically isolated from COPD patients or other controls without COPD were utilized to detect D -asparatic acid. To investigate exhaustively D-asparatic acid isomerization in the protein, we employed a paenidase I, D -asparatic asic specific endopeptidase, in combination with comparative two dimensional electrophoresis analysis.The endopeptidase sensitive proteins revealed decreased amounts of intensity in the proteins. The sensitive proteins were identified by mass spectrometry analysis. Furthermore, we studied the asparatic acid isomerization in vitro using cell culture system under cigarette smoke exposure. Results and discussion : In the proteins from COPD lung, 4 isomerized proteins, Prohibitin, Peroxiredoxin-2, Gkutathione S-transferase Pi, and serum amyloid p component, were detected significantly as evaluated by 30~40% compared to ~7% in control patients. Further, in vitro studies, cigarette smoke extracts induced ER stress marker and increased the ratio of the isomerized proteins. We conclude that protein isomerization process is involved in the pathogenesis of COPD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of Imatinib Mesylate on Pulmonary Vascular Remodeling of Allergic Vasculitis in Murine Model.
甲磺酸伊马替尼对小鼠模型过敏性血管炎肺血管重塑的影响。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Nobuhito Sasaki, Kohei Yamauchi, Miyuki Niisato, Hiromi Nagashima, Yu Utsumi, Naomi Suzuki, Yutaka Nakamura, Hitoshi Kobayashi, Takashi Sawai.]
通讯作者: Takashi Sawai.
気管支喘息における薬物治療の現状とテーラーメイド医療の展望
支气管哮喘药物治疗现状及个体化医疗前景
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Watanabe T, Nagashima M, Hirano T, et al., 山内広平]
通讯作者: 山内広平
DOI: 10.1099/jmm.0.016089-0
发表时间: 2010-10-01
期刊: JOURNAL OF MEDICAL MICROBIOLOGY
影响因子: 3
作者: [Matsui, Mikio, Fujii, Shin-ichiro, Yamauchi, Kohei]
通讯作者: Yamauchi, Kohei
Analysis of pulmonary allergic vasculitis with eosinophil infiltration in asthma model of mice.
哮喘小鼠模型肺变应性血管炎伴嗜酸性粒细胞浸润的分析
DOI: --
发表时间: 2010
期刊: Exp Lung Res.
影响因子: --
作者: [Yamauchi K, Sasaki N, Niisato M, Kamataki A, Shikanai T, Nakamura Y, Kobayashi H, Suwabe A, Kanno H, Sawai T, Inoue H]
通讯作者: Inoue H
36
    Trial to control airway inflammation by inflammation-inhibitory signal proteins, A20 and Pyrin
    • 批准号:
      19590908
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      YAMAUCHI Kohei
    • 依托单位:
    Analysis of bone-marrow derived fibroblasts involved in asthmatic airway remodeling and its interventional control of function
    • 批准号:
      17590802
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      YAMAUCHI Kohei
    • 依托单位:
    催熟技術改善のためのウナギ卵形成機構の解析
    • 批准号:
      17208016
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.7万
    • 财政年份:
      2005
    • 负责人:
      YAMAUCHI Kohei
    • 依托单位:
    Analysis airway of remodeling induced by CTGF
    • 批准号:
      14570560
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      YAMAUCHI Kohei
    • 依托单位:
    海外基金